Carbamazepine will lessen the extent or effect of pirfenidone by impacting hepatic enzyme CYP1A2 metabolism. Contraindicated. Usage of sturdy CYP1A2 inducers should be discontinued right before initiating pirfenidone and avoided during therapy eight An interplay in between host and environmental factors causes repetitive microinjuries of alveolar epithelial cells, simultaneous activation https://ericknzlcm.blog2freedom.com/29705234/rumored-buzz-on-emricasan